Using stem cells in multiple sclerosis therapies

This research characterized using stem cells in multiple sclerosis therapies, revealing immune dysregulation mechanisms in MS. Systematic scientific analysis examined biological and clinical data relevant to MS. Results identified dysregulation of immune tolerance as a key disease mechanism. Specific immune pathways drive neuroinflammatory damage in the brain and spinal cord. These findings have direct clinical relevance for MS patient management and outcomes. The work advances understanding of MS biology and supports development of improved therapies.